Siponimod
Products in Health Canada’s databases that list Siponimod as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 3
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 9
- Products in all
- 3
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| MAYZENT (0.25 MG) | 02496429 | Marketed | Novartis Pharmaceuticals Canada Inc. | |
| MAYZENT (2 MG) | 02496437 | Marketed | Novartis Pharmaceuticals Canada Inc. | |
| MAYZENT (1 MG) | 02543370 | Approved | Novartis Pharmaceuticals Canada Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- MAYZENTSeptember 1, 2026 · NOC 38224
- MAYZENTJune 16, 2025 · NOC 35524
- MAYZENTNovember 21, 2023 · NOC 32160
- MAYZENTJuly 4, 2023 · NOC 31101
- MAYZENTJune 28, 2023 · NOC 31071
- MAYZENTFebruary 13, 2023 · NOC 30119
- MAYZENTAugust 5, 2022 · NOC 28705
- MAYZENTMay 6, 2021 · NOC 25805
- MAYZENTFebruary 20, 2020 · NOC 23232